The market is propelled forward by an increase in federal funding for stem cell therapy. Here are five key vendors.
1. Holostem Advanced Therapies
2. JCR Pharmaceuticals
3. Organogenesis
4. Osiris Therapeutics
5. Vericel
More articles on biologics:
Cerapedics receives FDA IDE approval for study of P-15L Bone Graft in TLIF surgery: 4 things to know
4 things to know about mensenchymal stromal cells in spine
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
